R&D
Leading the Charge
Our groundbreaking science is the foundation of our innovative clinical program
First-in-Class Cancer Therapeutic
Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Clinical Program
We are focused on the clinical development of imetelstat in hematologic myeloid malignancies.
Leading the Charge
Our groundbreaking science is the foundation of our innovative clinical program
